Page 14 - Cor Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Correcting and Replacing: CinCor Reports Third Quarter Financial Results and Provides Corporate Update

WALTHAM, Mass., Nov. 04, 2022 CinCor Pharma, Inc. is re-issuing its earnings press release for the third quarter ended September 30, 2022, issued on November 3, 2022 at 8:00 am ET, to correct. | November 4, 2022

United statesComunidad autonoma de catalunaJustin thompsonBob yedidAmerican heart associationAmerican college of cardiologyInternational society of hypertensionHypertension researchExchange commissionDevelopment rd expensesEuropean society of cardiologyAmerican society of nephrologyCincor pharma incBusiness developmentCor pharmaChief executive

CinCor Pharma (CINC) Reports Publication of Phase 1 Multiple Ascending Dose Study Data

CinCor Pharma (CINC) Reports Publication of Phase 1 Multiple Ascending Dose Study Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mason freemanHypertension researchCincor pharma incCor pharmaChief medical officer

CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTerry coelhoMason freemanBob yedidExchange commissionAmerican heart associationAmerican college of cardiologyHypertension researchCincor pharma incCor pharmaChief medical officerAmerican collegeLooking statementsthisAnnual reportCincor pharma

10 Best-Performing Small-Cap Stocks of 2022

O’Shaughnessy Asset Management demonstrated the relative outperformance of smaller and cheaper stocks over the long-term.

United statesNorth carolinaHamilton beachRichard driehau driehausConnor lynaghJamese flynn deerfieldAmit wadhwaney moerusAllen gongJames westContinental intermodal groupCap value fundMorgan stanleyTransmedics group incSandstorm wellsite storage technologyTesla incTidewater inc

CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat at the Upcoming European Society of Cardiology 2022 Congress

22.08.2022 - WALTHAM, Mass., Aug. 22, 2022 (GLOBE NEWSWIRE) - CinCor Pharma, Inc. (NASDAQ: CINC) today announced that the company will present Phase 1 clinical data on lead candidate baxdrostat as part of a poster presentation at the upcoming European Society . Seite 1

Comunidad autonoma de catalunaMason freemanEuropean society of cardiologyCincor pharma incCor pharmaEuropean societyChief medical officer